Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients

被引:36
|
作者
Martin-Pena, Almudena [1 ]
Aguilar-Guisado, Manuela [1 ,2 ]
Espigado, Ildefonso [1 ,3 ]
Parody, Ricardo [3 ]
Cisneros, Jose Miguel [1 ,2 ]
机构
[1] Spanish Network Res Infect Dis REIPI, Seville, Spain
[2] Univ Hosp Virgen Rocio, Dept Infect Dis, Seville, Spain
[3] Univ Hosp Virgen Rocio, Dept Hematol, Seville, Spain
关键词
allogeneic stem cell; infection; mortality; risk factors; transplantation; CYTOMEGALOVIRUS-INFECTION; CLINICAL-FEATURES; FUNGAL-INFECTIONS; PERIPHERAL-BLOOD; RISK-FACTORS; MARROW; PREVENTION; OUTCOMES; DISEASE; ADULT;
D O I
10.1111/j.1399-0012.2010.01286.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
This is a prospective, observational study of a consecutive cohort of allogeneic hematopoietic stem cell transplantation (allo-HSCT) adult recipients conducted between July 2003 and May 2006, with the aim of identifying the current incidence, etiology, risk factors for infections and associated mortality up to two yr after allo-HSCT. Seventy-four episodes of infection were recorded in 38 patients, 50 consecutive adult patients underwent 54 allo-HSCT. The incidence of infection was 1.36 (68/50) episodes/patient after the first year of transplantation and 1.48 (74/50) episodes/patient after first two yr of transplantation. The most common syndrome was cytomegalovirus (CMV) infection, followed by catheter-related bloodstream infection and pneumonia. An etiological diagnosis was established in 85.1% of the episodes. Bacteria were the most common etiology (55.5%), followed by viruses (41.3%) and fungi (4.8%). CMV was the most common viral agent (73%), and all fungal infections were caused by molds. Myeloablative conditioning regimen, chronic graft-versus-host disease, and medical complications post-transplant were independent risk factors for infection. The global mortality two yr after transplantation was 32%, and death was infection related in 12%. In spite of advances, infections continue to be a common cause of morbidity and mortality following allo-HSCT.
引用
收藏
页码:468 / 474
页数:7
相关论文
共 50 条
  • [1] Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications
    Bonadio, M
    Morelli, G
    Mori, S
    Riccioni, R
    Papineschi, F
    Petrini, M
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (09) : 511 - 516
  • [2] Neurological complications in the recipients of allogeneic hematopoietic cell transplant
    Siegal, D.
    Keller, A.
    Xu, W.
    Bhuta, S.
    Loach, D.
    Kim, D.
    Walia, J.
    Kuruvilla, J.
    Lipton, J.
    Minden, M.
    Messner, H.
    Gupta, V.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 88 - 89
  • [3] NEUROLOGICAL COMPLICATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HCT) RECIPIENTS
    Crespo Ana, Puchol
    Bastida Carlota, Mayor
    Lopez Sofia, Diaz
    Alvarez Angela, Figuera
    Bueno Beatriz, Aguado
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 275 - 275
  • [4] Early infectious pulmonary complications in autologous hematopoietic stem cell transplant (HSCT) recipients
    Mahmoud, AA
    Litzow, MR
    Peters, SG
    Dispenzieri, A
    Tefferi, A
    Afessa, B
    [J]. CHEST, 2005, 128 (04) : 184S - 184S
  • [5] Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study
    Marina de Oliveira Rodrigues
    Lucia H. de Almeida Testa
    Ana Cláudia F. dos Santos
    Lilian P. Zanetti
    Luciana da Silva Ruiz
    Mair Pedro de Souza
    Vergílio R. Colturato
    Clarisse M. Machado
    [J]. Bone Marrow Transplantation, 2021, 56 : 2241 - 2247
  • [6] Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study
    de Oliveira Rodrigues, Marina
    de Almeida Testa, Lucia H.
    dos Santos, Ana Claudia F.
    Zanetti, Lilian P.
    da Silva Ruiz, Luciana
    de Souza, Mair Pedro
    Colturato, Vergilio R.
    Machado, Clarisse M.
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (09) : 2241 - 2247
  • [7] Prospective Randomized Study of Advance Directives in Allogeneic Hematopoietic Cell Transplant Recipients
    Muffly, Lori
    Ramirez, Yvette
    Burnash, Sarah
    Bisetti, Erin
    Rezvani, Andrew
    Sundaram, Vandana
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S199 - S199
  • [8] BK VIRUS INFECTION AND GENITOURINARY COMPLICATIONS IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Oshrine, Benjamin
    Laskin, Benjamin
    Furth, Susan
    Li, Yimei
    Bunin, Nancy
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : S97 - S98
  • [9] Cytomegalovirus Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Barlow, Ashley
    [J]. US PHARMACIST, 2021, 46 (04)
  • [10] Primary care for allogeneic hematopoietic stem cell transplant recipients
    Fulcher, Jill
    Hertz, Sherrie
    Bredeson, Christopher
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (06) : E225 - E226